Despite similar levels of hyperglycemia and similar daily insulin doses, only in progressors was activation of the NF-κB pathway observed, as indicated by the overexpression of TLR4, nuclear p65 and IL-6. This evidence concerns the gene NFKB1 and Hyperglycemia.